Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
- PMID: 30455511
- PMCID: PMC6239000
- DOI: 10.2471/BLT.18.223230
Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
References
-
- WHO handbook for guideline development. 2nd ed. Geneva: World Health Organization; 2014. Available from: http://www.who.int/publications/guidelines/handbook_2nd_ed.pdfhttp://[cited 2018 Sep 10].
-
- Active tuberculosis drug-safety monitoring and management (aDSM). Framework for implementation. Geneva: World Health Organization; 2015. Available from: http://apps.who.int/iris/bitstream/10665/204465/1/WHO_HTM_TB_2015.28_eng...http://[cited 2018 Sep 10].
-
- The ascent begins: tuberculosis research funding trends, 2005–2016. New York: Treatment Action Group; 2017. Available from: http://www.treatmentactiongroup.org/sites/default/files/TB_FUNDING_2017_...http://[cited 2018 Sep 10].
-
- WHO position statement on the use of delamanid for multidrug-resistant tuberculosis. Geneva: World Health Organization; 2018. Available from: http://www.who.int/tb/publications/2018/WHOPositionStatementDelamanidUse...http://[cited 2018 Sep 10].
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources